Medina-Serpas et al. provide a public spatial transcriptomic atlas of pancreas and pLN comprising defined stages of human T1D. Cross-platform validation revealed pancreatic inflammation and elevated lymphotoxin-β expression as a signature of T1D, persistent across tissues. These data support therapeutic targeting of the lymphotoxin/TNF pathway in T1D.